Elysium Health expands its wellness portfolio with the launch of Balance, a menopause-focused supplement leveraging NAD+ research to target symptoms and long-term health.
Elysium Health announced a new product launch, which is a positive company development but has no direct public market impact as the company is privately held.
Elysium Health, Inc. has introduced Balance, a new supplement designed to alleviate menopause symptoms while supporting long-term health. The product integrates clinically studied ingredients with the company's proprietary research on NAD+ biology to address both immediate relief and systemic wellness.
Balance is formulated to provide relief from menopause symptoms while utilizing NAD+ biology research to support long-term health.